You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天士力(600535.SH):用於治療Tourette綜合徵及慢性抽動障礙藥物芍麻止痙顆粒獲發藥品註冊批件
格隆匯 12-26 16:31

格隆匯12月26日丨天士力(600535.SH)公佈,公司獨家品種芍麻止痙顆粒收到國家藥監局核准簽發的《藥品註冊批件》。

公告顯示,芍麻止痙顆粒為公司獨家品種,適應症為Tourette綜合徵(抽動-穢語綜合徵)及慢性抽動障礙,具有平抑肝陽,息風止痙,清火豁痰的功效。根據產品説明書,該藥主要用於Tourette綜合徵(抽動-穢語綜合徵)及慢性抽動障礙,中醫辨證屬肝亢風動、痰火內擾者,症見頭面部、頸、肩、軀幹及四肢肌肉不自主的抽動或伴有口鼻、咽喉部的異常發聲,急躁易怒、手足心熱、睡卧不寧、大便偏幹、小便短黃、舌紅苔薄黃或薄黃膩。臨牀研究結果表明,芍麻止痙顆粒療效明確,安全性良好。

截至目前,公司對芍麻止痙顆粒項目累計研發總投入2469.58萬元人民幣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account